Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q99895: Variant p.Cys155Tyr

Chymotrypsin-C
Gene: CTRC
Feedback?
Variant information Variant position: help 155 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Cysteine (C) to Tyrosine (Y) at position 155 (C155Y, p.Cys155Tyr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (C) to large size and aromatic (Y) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In PCTT; the mutant is not secreted. Any additional useful information about the variant.


Sequence information Variant position: help 155 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 268 The length of the canonical sequence.
Location on the sequence: help DTIQVACLPEKDSLLPKDYP C YVTGWGRLWTNGPIADKLQQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         DTIQVACLPEKDSLLPKDYPCYVTGWGRLWTNGPIADKLQQ

Mouse                         DTIQVACIPEQDSLLPGDYPCYVTGWGRLWTNGPIAEVLQQ

Rat                           NTIQVACIPEEGSLLPQDYPCYVTGWGRLWTNGPIAEVLQQ

Bovine                        DTIQVACLPEEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQ
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 30 – 268 Chymotrypsin-C
Domain 30 – 267 Peptidase S1
Disulfide bond 155 – 222
Beta strand 155 – 160



Literature citations
Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis.
Masson E.; Chen J.M.; Scotet V.; Le Marechal C.; Ferec C.;
Hum. Genet. 123:83-91(2008)
Cited for: VARIANTS PCTT THR-73; TYR-155; SER-217; ARG-217; ILE-235; 247-LYS--ARG-254 DEL AND TRP-254; VARIANTS HIS-162; GLU-172 AND VAL-200; Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk.
Beer S.; Zhou J.; Szabo A.; Keiles S.; Chandak G.R.; Witt H.; Sahin-Toth M.;
Gut 62:1616-1624(2013)
Cited for: VARIANTS ARG-18; TYR-35 AND SER-227; VARIANTS PCTT ARG-178 AND GLU-250; CHARACTERIZATION OF VARIANTS ARG-18; TYR-35; ARG-48; ARG-61; ARG-220 AND GLN-254; CHARACTERIZATION OF VARIANTS PCTT VAL-32; THR-73; TYR-155; ARG-178; ARG-217; SER-217; ILE-235; 247-LYS--ARG-254 DEL; LEU-249; GLU-250 AND TRP-254;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.